MoneyWorks4Me

Suven Life Sciences - Quaterly Results

04 Nov 2023 Evaluate
The sales moved down -30.23% to Rs. 30.60 millions for the September 2023 quarter as compared to Rs. 43.86 millions during the corresponding quarter last year.The Total Profit for the quarter ended September 2023 of Rs. 27.55 millions grew from Rs.-89.33 millions Operating profit Margin for the quarter ended September 2023 improved to -29.34% as compared to -72.44% of corresponding quarter ended September 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 30.60 43.86 -30.23 68.57 79.25 -13.48 135.39 118.44 14.31
Other Income 51.42 2.06 2396.12 107.82 6.42 1579.44 84.49 16.01 427.73
PBIDT -29.34 -72.44 -59.50 -40.89 -138.74 -70.53 -192.95 -350.41 -44.94
Interest 0.42 0.69 -39.13 0.93 1.71 -45.61 2.89 5.30 -45.47
PBDT 44.81 -73.13 -161.27 32.75 -80.45 -140.71 -135.84 -318.55 -57.36
Depreciation 17.26 16.20 6.54 33.91 32.01 5.94 65.43 43.93 48.94
PBT 27.55 -89.33 -130.84 -1.16 -112.46 -98.97 -201.27 -362.48 -44.47
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 27.55 -89.33 -130.84 -1.16 -112.46 -98.97 -201.27 -362.48 -44.47
Equity 218.07 145.38 50.00 218.07 145.38 50.00 218.07 145.38 50.00
PBIDTM(%) -95.88 -165.16 -41.95 -59.63 -175.07 -65.94 -142.51 -295.85 -51.83
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..